AFP and hepatocellular carcinoma: To identify HCC at an early treatable stage, the American Association for the Study of Liver Diseases (AASLD) recommends surveillance of adults with cirrhosis by ultrasound with or without alpha-fetoprotein (AFP) every 6 months [4].